Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
KBI Biopharma Extends and Expands Commercial Contract with Leading Global Pharmaceutical Company
Jul 23, 2024•about 2 years ago
Contract Type
contract
DurhamManufacturingBiotechnology
Description
KBI Biopharma, Inc. has extended and expanded its manufacturing contract with a leading global pharmaceutical company. The renewed contract extends through 2029 with a notable amendment that outlines a purchase commitment for two therapeutic products representing an incremental value of approximately $250 million through the end of the renewed term. Additionally, KBI completed a successful FDA regulatory inspection enabling the company’s North Carolina operations to begin providing a mammalian drug substance commercially to one of its key strategic customers, demonstrating KBI’s ability to act as a preferred partner for large volume commercial therapeutic manufacturing.
Company Information
Company
KBI Biopharma
Location
Durham, North Carolina, United States
About
KBI Biopharma is an award-winning biopharmaceutical contract services organization providing fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally.
With each of our 500+ client partners, we have worked closely to personalize and rapidly accelerate their drug development programs. Built upon a foundation of world-class analytical capabilities, we deliver efficient process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs.
KBI is proud to be a JSR Life Sciences Company.
DurhamManufacturingBiotechnology